Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning ; volume:12 ; number:1 ; day:16 ; month:8 ; year:2022 ; pages:1-14 ; date:12.2022
Scientific reports ; 12, Heft 1 (16.8.2022), 1-14, 12.2022
- Urheber
-
Zucco, Adrian G.
Agius, Rudi
Svanberg, Rebecka
Moestrup, Kasper S.
Marandi, Ramtin Z.
MacPherson, Cameron Ross
Lundgren, Jens
Ostrowski, Sisse R.
Niemann, Carsten U.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17953-y
- URN
-
urn:nbn:de:101:1-2022110322001296222106
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zucco, Adrian G.
- Agius, Rudi
- Svanberg, Rebecka
- Moestrup, Kasper S.
- Marandi, Ramtin Z.
- MacPherson, Cameron Ross
- Lundgren, Jens
- Ostrowski, Sisse R.
- Niemann, Carsten U.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Personalized Explainable Learner Implicit Friend Recommendation Method
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model
Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes
Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
A precision functional atlas of personalized network topography and probabilities
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
A Personalized Explainable Learner Implicit Friend Recommendation Method
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model
Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes
Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
A precision functional atlas of personalized network topography and probabilities
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
A Personalized Explainable Learner Implicit Friend Recommendation Method
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model
Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes
Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
A precision functional atlas of personalized network topography and probabilities
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Coronavirus - COVID-19 - SARS-COV-2